XML 51 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Balance Sheet Details - Short Term Marketable Securities, Available for Sale (Detail) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Debt securities, available for sale:      
Debt securities, available-for-sale, amortized cost $ 210.7 $ 107.3  
Debt Securities, gross unrealized gains 0.0 0.0  
Debt securities, gross unrealized losses (0.1) (0.2)  
Short-term marketable securities 210.6 107.1  
Debt Securities, Available-for-sale and Equity Securities, Amortized Cost 212.7    
Total marketable securities, cost or amortized cost 248.6 107.1  
Total marketable securities, gross unrealized gains 36.0    
Total marketable securities, gross unrealized losses (0.1)    
Debt securities with maturities of less than 12 months 92.7    
Debt securities with maturities of more than 12 months $ 14.4    
Debt securities held maximum contractual maturities 16 months    
Net gain recognized on equity securities      
Net gains recognized during the period on equity securities $ 80.1 0.0 $ 0.0
Less: Net gains recognized during the period on equity securities sold during the period (44.1) 0.0 0.0
Unrealized gains recognized during the reporting period on equity securities still held at the reporting date 36.0 0.0 $ 0.0
U.S. government agencies      
Debt securities, available for sale:      
Debt securities, available-for-sale, amortized cost 173.2 87.5  
Debt Securities, gross unrealized gains 0.0 0.0  
Debt securities, gross unrealized losses (0.1) (0.2)  
Short-term marketable securities 173.1 87.3  
Commercial paper      
Debt securities, available for sale:      
Debt securities, available-for-sale, amortized cost 36.2 14.7  
Debt Securities, gross unrealized gains 0.0 0.0  
Debt securities, gross unrealized losses 0.0 0.0  
Short-term marketable securities 36.2 14.7  
Corporate debt      
Debt securities, available for sale:      
Debt securities, available-for-sale, amortized cost 1.3 5.1  
Debt Securities, gross unrealized gains 0.0 0.0  
Debt securities, gross unrealized losses 0.0 0.0  
Short-term marketable securities 1.3 $ 5.1  
Equity investment in Tandem Diabetes Care, Inc      
Short-Term Marketable Securities      
Equity investment in Tandem Diabetes Care, Inc., cost or amortized cost 2.0    
Equity investment in Tendem Diabetes Care, Inc., gross unrealized gains 36.0    
Equity investment in Tandem Diabetes Care, inc., gross unrealized losses 0.0    
Equity Invesment in Tandem Diabetes Care, Inc., estimated market value $ 38.0